scholarly article | Q13442814 |
P50 | author | Padraic G. Fallon | Q42944857 |
Emily Hams | Q54378130 | ||
Arvydas Maminishkis | Q55762128 | ||
Sean P. Saunders | Q55948319 | ||
Sarah L Doyle | Q55948328 | ||
Ed C. Lavelle | Q55948337 | ||
Clair Gardiner | Q61221569 | ||
Kelly Mulfaul | Q64428802 | ||
Kiva Brennan | Q89449463 | ||
P2093 | author name string | Marian M Humphries | |
Matthew Campbell | |||
Paul F Kenna | |||
Peter Humphries | |||
Ema Ozaki | |||
Peter Adamson | |||
Anna-Sophia Kiang | |||
James Keaney | |||
P2860 | cites work | The inflammasomes | Q24304087 |
Ranibizumab and bevacizumab for neovascular age-related macular degeneration | Q24616209 | ||
DICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88 | Q24621930 | ||
Innate immune recognition | Q27860721 | ||
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling | Q29615457 | ||
Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression | Q29615589 | ||
P433 | issue | 230 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | macular degeneration | Q27429789 |
neovascularization | Q1281049 | ||
P304 | page(s) | 230ra44 | |
P577 | publication date | 2014-04-01 | |
P1433 | published in | Science Translational Medicine | Q1573955 |
P1476 | title | IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration | |
P478 | volume | 6 |
Q47427948 | Advances in Age-related Macular Degeneration Understanding and Therapy |
Q55057811 | Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines. |
Q47123727 | An Induced Pluripotent Stem Cell Patient Specific Model of Complement Factor H (Y402H) Polymorphism Displays Characteristic Features of Age-Related Macular Degeneration and Indicates a Beneficial Role for UV Light Exposure. |
Q37088454 | CFH Y402H polymorphism and the complement activation product C5a: effects on NF-κB activation and inflammasome gene regulation |
Q30612009 | Cholesterol-mediated activation of acid sphingomyelinase disrupts autophagy in the retinal pigment epithelium |
Q37731893 | Chronic, Systemic Interleukin-18 Does Not Promote Macular Degeneration or Choroidal Neovascularization |
Q38819720 | Complement Component C5a Primes Retinal Pigment Epithelial Cells for Inflammasome Activation by Lipofuscin-mediated Photooxidative Damage |
Q34526132 | DICER1/Alu RNA dysmetabolism induces Caspase-8-mediated cell death in age-related macular degeneration |
Q36626060 | Defects in retinal pigment epithelial cell proteolysis and the pathology associated with age-related macular degeneration. |
Q47202861 | Diverse roles of macrophages in intraocular neovascular diseases: a review. |
Q38956279 | Doyne lecture 2016: intraocular health and the many faces of inflammation |
Q90317718 | EASIX and mortality after allogeneic stem cell transplantation |
Q47734998 | Evidence for the activation of pyroptotic and apoptotic pathways in RPE cells associated with NLRP3 inflammasome in the rodent eye. |
Q87888119 | Eye diseases: a new use for interleukin-18 in sight |
Q38851309 | Friend or Foe? Resident Microglia vs Bone Marrow-Derived Microglia and Their Roles in the Retinal Degeneration |
Q91782625 | IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis |
Q92404834 | IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases |
Q43009110 | IL-18 is not therapeutic for neovascular age-related macular degeneration |
Q36569352 | IL-33 amplifies an innate immune response in the degenerating retina. |
Q33673256 | Identification of small molecule inhibitors of Interleukin-18. |
Q35161079 | Inflammasomes Induced by 7-Ketocholesterol and Other Stimuli in RPE and in Bone Marrow-Derived Cells Differ Markedly in Their Production of IL-1β and IL-18. |
Q26768520 | Inflammation and its role in age-related macular degeneration |
Q35755942 | Inflammatory Mechanisms of Age-related Macular Degeneration |
Q100945794 | Inhibiting the NLRP3 inflammasome with MCC950 ameliorates retinal neovascularization and leakage by reversing the IL-1β/IL-18 activation pattern in an oxygen-induced ischemic retinopathy mouse model |
Q39324207 | Interleukin-33 regulates tissue remodelling and inhibits angiogenesis in the eye. |
Q41520482 | Melatonin antagonizes interleukin-18-mediated inhibition on neural stem cell proliferation and differentiation |
Q26799766 | NLRP3 Inflammasome and Pathobiology in AMD |
Q36512570 | NLRP3 Upregulation in Retinal Pigment Epithelium in Age-Related Macular Degeneration |
Q38423371 | NLRP3 at the interface of metabolism and inflammation. |
Q26995315 | NLRP3 inflammasome: activation and regulation in age-related macular degeneration |
Q35582494 | Nod-like receptor protein-3 inflammasome plays an important role during early stages of wound healing |
Q36940296 | Oxidative stress, innate immunity, and age-related macular degeneration |
Q28818003 | PKR promotes choroidal neovascularization via upregulating the PI3K/Akt signaling pathway in VEGF expression |
Q86184474 | Reply to IL-18 is not therapeutic for neovascular age-related macular degeneration |
Q36595519 | Retinal Ganglion Cell Loss is Delayed Following Optic Nerve Crush in NLRP3 Knockout Mice. |
Q59354960 | Role of IL-18 induced Amphiregulin expression on virus induced ocular lesions |
Q47282467 | Social stress induces neurovascular pathology promoting depression |
Q58713704 | Systemic immunosuppression and risk of age-related macular degeneration |
Q35001511 | Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives |
Q38596848 | The NLRP3 Inflammasome and its Role in Age-Related Macular Degeneration |
Q39024579 | The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target |
Q35807878 | The peptidomimetic Vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease |
Search more.